Del. Court Says Pharma Co. Must Delist 'Orange Book' Patent
By Nadia Dreid · November 18, 2022, 7:39 PM EST
Jazz Pharmaceuticals has two weeks to ask the U.S. Food and Drug Administration to pull a patent that purportedly covers a narcolepsy drug from the agency's so-called Orange Book after a...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login